In chronic lymphocytic leukemia (CLL), malignant cells exploit the IRE1α-XBP1 pathway to overproduce secretory immunoglobulin M (sIgM), driving myeloid-derived suppressor cells (MDSCs) accumulation and enhancing their immunosuppressive activity215. Here, ERN1 is linked to B-cell chronic lymphocytic leukemia.